FDA Advisory Letters Notify Firms of Federal Law Violations
Summary
The FDA's Center for Veterinary Medicine is posting Untitled Letters on its website to inform the public about firms violating federal law. These letters notify firms of violations that do not meet the threshold for a Warning Letter but still require correction.
What changed
The FDA's Center for Veterinary Medicine (CVM) has begun posting Untitled Letters on its website. These letters are issued to individuals and firms for violations of the Federal Food, Drug and Cosmetic Act that do not meet the regulatory significance threshold for a Warning Letter. The CVM aims to keep the public informed about these violations and provide firms an opportunity to make prompt, voluntary corrections.
While Untitled Letters do not carry the same weight as Warning Letters, they serve as formal notification of violations and document FDA's awareness of non-compliance. Firms receiving an Untitled Letter should review the cited violations and take necessary corrective actions to come into compliance and avoid potential further FDA enforcement. The posting of these letters on the CVM website increases transparency regarding regulatory compliance within the animal health industry.
What to do next
- Review CVM Untitled Letters posted on the FDA website
- Assess cited violations for potential non-compliance
- Implement corrective actions as necessary to ensure compliance with federal law
Archived snapshot
Mar 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
When there is a violation of the Federal Food, Drug and Cosmetic Act, the FDA may, depending on the nature of the violation, give individuals and firms an opportunity to make voluntary and prompt corrections by taking an advisory action.
Advisory actions include Untitled and Warning Letters. Warning Letters are issued to achieve voluntary compliance and to establish prior notice. Warning Letters are issued for violations of regulatory significance that may lead to other enforcement action, such as an injunction, if not promptly and adequately corrected. A Warning Letter is the agency's principal means of achieving prompt voluntary compliance with the Act. Warning Letters are posted on FDA’s website.
An Untitled Letter cites violations that do not meet the threshold of regulatory significance for a Warning Letter. However, Untitled Letters serve as an initial notification to firms that FDA is aware of their violations of federal law, and they document formal notification by FDA to the person or firm. They also allow the firm to come into compliance without further FDA action.
The Center for Veterinary Medicine (CVM) is posting Untitled Letters on its website to keep the public informed about persons or firms violating the law.
Untitled Letters
Warning Letters
Additional Resources
- Issuance of Untitled Letters
- Freedom of Information
Content current as of:
05/01/2023
-
Related changes
Get daily alerts for FDA Untitled Letters
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA Untitled Letters publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.